Novo Nordisk Shares Drop After Trump Vows to Cut Drug Prices

Impact of Trump's Comments on Novo Nordisk

• 📉 Novo Nordisk shares experienced a significant drop of up to 6.4% in early Friday trading.
• 🗣️ This decline followed US President Donald Trump's signal that the prices of the Danish drugmaker's weight-loss drugs would be reduced.

Trump Administration's Drug Pricing Policy

• ⚖️ Since January, Trump has aimed to reduce the disparity between US and international drug prices.
• 🇺🇸 The Most Favored Nation policy mandates that the US government will not require drug manufacturers to charge more than they do in other wealthy nations.
• 📍 Trump made these remarks during a White House event focused on fertility treatments and drug pricing.

Ozempic and Weight-Loss Drugs

• ❓ When asked by reporters about a drug he mentioned would become less expensive, Trump referred to Ozempic or a "fat loss drug."
• 💊 Although Ozempic is approved for diabetes, it contains the same active ingredient as Novo Nordisk's successful weight-loss drug, Wegovy.
• 📈 In the US, Ozempic is frequently used off-label for obesity and is often cited generically in discussions about weight-loss drugs.

Company Response

• 💬 A Novo Nordisk spokesperson stated that the company is engaged in discussions with the Trump administration regarding the Most Favored Nation order.